TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kintor Pharmaceutical Ltd ( (HK:9939) ) has shared an update.
Kintor Pharmaceutical Limited has announced its upcoming annual general meeting scheduled for June 10, 2025, in Suzhou, China. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of auditors, and authorization for the board to manage share capital activities. These resolutions are pivotal for the company’s governance and strategic direction, potentially impacting its operational efficiency and shareholder value.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It operates with a market focus on developing and commercializing innovative therapies for unmet medical needs, particularly in the areas of oncology and dermatology.
Average Trading Volume: 4,039,140
Technical Sentiment Signal: Sell
Current Market Cap: HK$554.8M
For a thorough assessment of 9939 stock, go to TipRanks’ Stock Analysis page.